Table 3. Cox regression model for predicting survival and complete remission duration (CRD) in Patients with Acute Myeloid Leukemia and Acute lymphoblastic leukemia.

	Beta	Standard Error	t-value	Wald Statistic	P-value
Univariate Survival as predicted by proteasome protein in AML
In all patients	0.0003	0.0001	4.4383	19.6988	<0.00001
In Intermediate cytogenetic group	0.000190	0.000086	2.222028	4.937406	0.026
In poor Cytogenetic group	0.000298	0.000087	3.418611	11.68690	0.0006
Multivariate in AML patients
Proteasome	0.0002	0.0001	3.0434	9.2622	0.002
Cytogenetic grouping	0.7860	0.1859	4.2286	17.8812	<0.00001
Age grouping (<70 vs >70)	0.6489	0.1986	3.2673	10.6751	0.001
Performance status (<2 vs >2)	0.6099	0.2130	2.8631	8.1974	0.004
CRD in AML
Ch-L/P	0.2956	0.1678	1.7619	3.1041	0.08
Cas-L/P	0.1460	0.0821	1.7774	3.1591	0.08
Univariate, survival in ALL
Proteasome	0.00001	0.0000	1.6713	2.7934	0.09
Ch-L/P	−1.3914	0.6323	−2.2005	4.8422	0.03
Cas-L/P	−0.7028	0.3980	−1.7661	3.1191	0.08
Univariate, CRD in ALL
Ubiquitin	0.0051	0.0027	1.9299	3.7247	0.05
Ch-L/P	−1.1975	0.6623	−1.8083	3.2699	0.07
Cas-L/P	−1.8295	0.7336	−2.4939	6.2195	0.01